Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael L Johnson

Showing results (131-140 of 190) with videos related to

Pageof 19
Sort By:
Journal of Evaluation in Clinical Practice|February 10, 2015
Which risk-adjustment index performs better in predicting 30-day mortality? A systematic review and meta-analysisMo Yang, Hemalkumar B Mehta, Vishal Bali, et al.
Pharmacotherapy|February 28, 2021
Comparative treatment effectiveness of oral fingolimod and conventional injectable disease-modifying agents in multiple sclerosisJagadeswara R Earla, George J Hutton, Douglas J Thornton, et al.
Exploratory Research in Clinical and Social Pharmacy|April 28, 2022
Factors associated with oral fingolimod use over injectable disease- modifying agent use in multiple sclerosisJagadeswara Rao Earla, George J Hutton, J Douglas Thornton, et al.
Breast Cancer Research and Treatment|August 15, 2022
Dose-dependent relation between metformin and the risk of hormone receptor-positive, her2-negative breast cancer among postmenopausal women with type-2 diabetesSoumya G Chikermane, Manvi Sharma, Susan M Abughosh, et al.
Current Medical Research and Opinion|June 13, 2026
Evaluating time to treatment intensification among drug naïve type 2 diabetes patients: a comparison of initial combination therapy vs step-therapy approachesZahra Majd, Sai S Cheruvu, Hua Chen, et al.
Diagnostic Microbiology and Infectious Disease|November 8, 2011
A model to predict mortality following Pseudomonas aeruginosa bacteremiaElizabeth B Hirsch, Jessica M Cottreau, Kai-Tai Chang, et al.
Veterinary Research|November 1, 2006
Use of a case-control study and geographic information systems to determine environmental and demographic risk factors for canine leptospirosisGeorge S Ghneim, Joshua H Viers, Bruno B Chomel, et al.
Research and Practice in Thrombosis and Haemostasis|October 19, 2019
Warfarin vs. apixaban in nonvalvular atrial fibrillation, and analysis by concomitant antiarrhythmic medication use: A national retrospective studyMatthew A Wanat, Xin Wang, Rutugandha Paranjpe, et al.
Substance Use & Misuse|November 24, 2015
Comparison of Diabetes Risk Following Smoking Cessation Treatment Using Varenicline Versus Bupropion Among Obese SmokersMo Yang, Hua Chen, Michael L Johnson, et al.
Gastroenterology|October 19, 2005
National adherence to evidence-based guidelines for the prescription of nonsteroidal anti-inflammatory drugsNeena S Abraham, Hashem B El-Serag, Michael L Johnson, et al.
Pageof 19

Showing results (131-140 of 190) with videos related to

Sort By:
Pageof 19
Journal of Evaluation in Clinical Practice|February 10, 2015
Which risk-adjustment index performs better in predicting 30-day mortality? A systematic review and meta-analysisMo Yang, Hemalkumar B Mehta, Vishal Bali, et al.
Pharmacotherapy|February 28, 2021
Comparative treatment effectiveness of oral fingolimod and conventional injectable disease-modifying agents in multiple sclerosisJagadeswara R Earla, George J Hutton, Douglas J Thornton, et al.
Exploratory Research in Clinical and Social Pharmacy|April 28, 2022
Factors associated with oral fingolimod use over injectable disease- modifying agent use in multiple sclerosisJagadeswara Rao Earla, George J Hutton, J Douglas Thornton, et al.
Breast Cancer Research and Treatment|August 15, 2022
Dose-dependent relation between metformin and the risk of hormone receptor-positive, her2-negative breast cancer among postmenopausal women with type-2 diabetesSoumya G Chikermane, Manvi Sharma, Susan M Abughosh, et al.
Current Medical Research and Opinion|June 13, 2026
Evaluating time to treatment intensification among drug naïve type 2 diabetes patients: a comparison of initial combination therapy vs step-therapy approachesZahra Majd, Sai S Cheruvu, Hua Chen, et al.
Diagnostic Microbiology and Infectious Disease|November 8, 2011
A model to predict mortality following Pseudomonas aeruginosa bacteremiaElizabeth B Hirsch, Jessica M Cottreau, Kai-Tai Chang, et al.
Veterinary Research|November 1, 2006
Use of a case-control study and geographic information systems to determine environmental and demographic risk factors for canine leptospirosisGeorge S Ghneim, Joshua H Viers, Bruno B Chomel, et al.
Research and Practice in Thrombosis and Haemostasis|October 19, 2019
Warfarin vs. apixaban in nonvalvular atrial fibrillation, and analysis by concomitant antiarrhythmic medication use: A national retrospective studyMatthew A Wanat, Xin Wang, Rutugandha Paranjpe, et al.
Substance Use & Misuse|November 24, 2015
Comparison of Diabetes Risk Following Smoking Cessation Treatment Using Varenicline Versus Bupropion Among Obese SmokersMo Yang, Hua Chen, Michael L Johnson, et al.
Gastroenterology|October 19, 2005
National adherence to evidence-based guidelines for the prescription of nonsteroidal anti-inflammatory drugsNeena S Abraham, Hashem B El-Serag, Michael L Johnson, et al.
Pageof 19